Loading...
Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer’s prevention and early intervention
Keeney, Jeriel Thomas-Richard Ibrahimi, Shaher Zhao, Liqin
Keeney, Jeriel Thomas-Richard
Ibrahimi, Shaher
Zhao, Liqin
Citations
Altmetric:
Abstract
Three major genetic isoforms of apolipoprotein E (ApoE) exist in humans, ApoE2, ApoE3, and ApoE4 leading to differences in susceptibility to Alzheimer’s disease (AD). This study investigated the impact of human ApoE isoforms on brain metabolic pathways involved in glucose utilization and amyloid-β (Aβ) degradation, two major areas that are significantly perturbed in preclinical AD. Hippocampal RNA samples from middle-aged female mice with targeted human ApoE2, ApoE3, and ApoE4 gene replacement were comparatively analyzed with a qRT-PCR custom array for the expression of 85 genes involved in insulin/insulin-like growth factor (Igf) signaling. Consistent with its protective role against AD, ApoE2 brain exhibited the most metabolically robust profile among the three ApoE genotypes. When compared to ApoE2 brain, both ApoE3 and ApoE4 brains exhibited markedly reduced levels of Igf1, insulin receptor substrates (Irs), and facilitated glucose transporter 4 (Glut4), indicating reduced glucose uptake. Additionally, ApoE4 brain exhibited significantly decreased Pparg and insulin-degrading enzyme (Ide) indicating further compromised glucose metabolism and Aβ dysregulation associated with ApoE4. Protein analysis showed significantly decreased Igf1, Irs, and Glut4 in ApoE3 brain, and Igf1, Irs, Glut4, Pparg, and Ide in ApoE4 brain compared to ApoE2 brain. These data provide the first documented evidence that human ApoE isoforms differentially affect brain insulin/Igf signaling and downstream glucose and amyloid metabolic pathways, illustrating a potential mechanism for their differential risk in AD. A therapeutic strategy that enhances brain insulin/Igf1 signaling activity to a more robust ApoE2-like phenotype favoring both energy production and amyloid homeostasis holds promise for AD prevention and early intervention.
Description
Date
2015-06-10
Journal Title
Journal ISSN
Volume Title
Publisher
IOS Press
Collections
Files
Loading...
zhao_human.pdf
Adobe PDF, 1.12 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Alzheimer’s disease (AD), Apolipoprotein E2 (ApoE2), Apolipoprotein E3 (ApoE3), Apolipoprotein E4 (ApoE4), Insulin-like growth factor 1 (Igf1), Insulin-degrading enzyme (Ide), Glucose transporter 4 (Glut4), Peroxisome proliferator-activated receptor gamma (Pparg), Glucose metabolism, Early intervention
Citation
Keeney, Jeriel Thomas-Richard, Shaher Ibrahimi, and Liqin Zhao. “Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer’s Prevention and Early Intervention.” Journal of Alzheimer’s disease : JAD 48.2 (2015): 411–424.